[DISCLOSURE] Imagis (115610) has obtained a patent related to movement reasoning method and device based on bio signal, it announced on July 11.

July 11, 2016

[DISCLOSURE] GNCO (065060) will issue convertible bonds worth 2.3 billion won (US$2 million) for private offering to finance operations, it announced on July 11. The conversion period is between July 12, 2017 and June 12, 2019.

July 11, 2016

[DISCLOSURE] EQUISnZAROO (058530) has decided on a 4.5 billion won (US$3.9 million) capital increase with third party allotment to finance operations, it announced on July 11. It will issue 924,024 shares and offer to First Village, its largest shareholder, and Woojin Fashion Biz. The listing date is July 27.　It will also issue 2,258,720 shares for Yun Eui-seok and 12 others for an 11 billion won capital increase to finance operations, the biotechnology and multi-brand distribution company said

July 11, 2016

[DISCLOSURE] Dawonsys (068240) has won National Fusion Research Institute’s bid to manufacture and test fusion power supply system for KSTAR (Korea Superconducting Tokamak Advanced Research), the company announced on July 11. The bidding price is 15.2 billion won (US$13.1 million), amounting to 22.65 percent of its recent revenue.

July 11, 2016

[DISCLOSURE] Feelingk (064800) announced on July 11 that it has acquired 30 percent stake (4,286 shares) of Nzonesoft for 1.5 billion won (US$1.3 million) through capital increase with third party allotment. This amounts to 5.81 percent of its equity capital.

July 11, 2016

[DISCLOSURE] Dongkuk Steel Mill (001230) reported on July 11 that its operating profit rose to 99 billion won (US$85.6 million) in the second quarter, a 156.4 percent leap from the same period last year. The revenue decreased by 1.5 percent to 1.2 trillion won and net profit fell 59.6 percent to 36.5 billion won.

July 11, 2016

[DISCLOSURE] Kolon Life Science (102940) announced on July 11 that it has filed for approval from the Ministry of Food and Drug Safety to market Invossa, a treatment for osteoarthritis. 　Developed under the name Tissuegene-C, it is the first gene therapy to seek approval in Korea, and the first allogeneic cell therapy in the world. Invossa treats degenerative arthritis by injecting genetically modified cartilage cells and alleviates pains, slows down degeneration and improves cartilages, the com

July 11, 2016

[DISCLOSURE] Hyundai Motor (005380) has acquired money market trust worth 70 billion won (US$60.6 million) from its affiliate HMC Investment Securities, the company announced on July 8.

July 8, 2016

[DISCLOSURE] Samsung Heavy Industries (010140) acknowledged that it is seeking to raise capital but did not provide specifics, in response to Korea Exchange’s inquiry regarding media reports on the possibility, in a statement on July 8.

July 8, 2016

[DISCLOSURE] LS (006260) announced on July 8 that Seoul High Court has ruled against the company and eight others and told them to pay KEPCO  59.4 billion won (US$51.4 million) in compensation for unfair collective practice. They have been accused of colluding for KEPCO’s power line bid. 　

July 8, 2016

[DISCLOSURE] Tailim Packaging (011280) will guarantee a 92.7 billion won (US$80.2 million) debt of its affiliate Wolsan Paper, it announced on July 8. This amounts to 24.81 percent of its equity capital.

July 8, 2016

[DISCLOSURE] Dongwon (003580) will reduce capital by consolidating its stocks at 5:1 ratio down to 1,278,717 shares, the company announced on July 8, to improve its financial structure. The base date is Sept. 30. The capital will drop to 6.4 billion won (US$5.5 million). Korea Exchange suspended trading of Dongwon stocks, it announced in a separate statement.

July 8, 2016

[DISCLOSURE] AmorePacific (090430) reported on July 8 that three relatives of the largest shareholder and chairman Suh Kyung-bae have sold their 1,264 shares from July 5 to 8.

July 8, 2016

[DISCLOSURE] Hanwha Chemical (009830) will contribute 18,229 shares worth 9.1 billion won (US$7.9 million) to its affiliate Hanwha Chemical Overseas Holdings to secure operation funds and to improve its financial structure, it announced on July 8.

July 8, 2016

[DISCLOSURE] Avista (090370) has decided on an 1.7 billion won (US$1.5 million) capital increase to finance operations, it announced on July 8. It will issue 615,986 stocks and the listing date is July 21.

July 8, 2016